Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

OBL Corner

Editor's Corner
The Role of Office-Based Interventional Suites in Healthcare During the Second Wave of the COVID-19 Pandemic
10/18/2021
Dr. Walker discusses the role of office-based interventional suites during the second wave of COVID-19.
Dr. Walker discusses the role of office-based interventional suites during the second wave of COVID-19.
Dr. Walker discusses the role of...
10/18/2021
Vascular Disease Management
Video
The Role of Office-Based Interventional Suites in Healthcare During the Second Wave of the COVID-19 Pandemic
10/18/2021
In this video, Editor-in-Chief Craig Walker discusses the role of office-based interventional suites in during the second wave of the COVID-19 pandemic.
In this video, Editor-in-Chief Craig Walker discusses the role of office-based interventional suites in during the second wave of the COVID-19 pandemic.
In this video, Editor-in-Chief...
10/18/2021
Vascular Disease Management
OBLs and the Role of OEIS
Video
Office-Based Labs and the Role of OEIS
10/12/2021


OEIS

Join Drs. Wiechmann, Walker, and Beasley as they discuss OBLs and the role of OEIS. Recorded at AMP2021.
Join Drs. Wiechmann, Walker, and Beasley as they discuss OBLs and the role of OEIS. Recorded at AMP2021.
Join Drs. Wiechmann, Walker, and...
10/12/2021
Vascular Disease Management
OBL Corner
Supply Management in an Office-Based Endovascular Center
09/20/2021
Good supply management is critical to both the clinical and financial success of the OEC.
Good supply management is critical to both the clinical and financial success of the OEC.
Good supply management is...
09/20/2021
Vascular Disease Management
OBL Corner
Protecting Reimbursement Is a Never-Ending Challenge
08/01/2021
If CMS continues this trend of slashing our reimbursement rates, it will have a devastating impact on the well-documented improvement in clinical outcomes in revascularization performed in the outpatient setting.
If CMS continues this trend of slashing our reimbursement rates, it will have a devastating impact on the well-documented improvement in clinical outcomes in revascularization performed in the outpatient setting.
If CMS continues this trend of...
08/01/2021
Vascular Disease Management
Access Management
Access Decisions in the Office-Based Lab
07/20/2021
Arterial access is a critical, if not the critical, component of vascular interventional procedures due to the morbidity and mortality of a bleeding access site.
Arterial access is a critical, if not the critical, component of vascular interventional procedures due to the morbidity and mortality of a bleeding access site.
Arterial access is a critical,...
07/20/2021
Vascular Disease Management
OBL Corner
Disaster Preparedness in the OBL
06/29/2021
Managing the impact of a natural disaster on an OBL is difficult. The lessons learned from our experience in surviving direct hits from two hurricanes may be of value to others.
Managing the impact of a natural disaster on an OBL is difficult. The lessons learned from our experience in surviving direct hits from two hurricanes may be of value to others.
Managing the impact of a natural...
06/29/2021
Vascular Disease Management
Dr. Jeffrey Carr
Office-Based Labs
Office-Based Labs: An Evolving Healthcare Model
06/10/2021
There are several key considerations before deciding to launch out on your own.
There are several key considerations before deciding to launch out on your own.
There are several key...
06/10/2021
Vascular Disease Management
News
HST Pathways Announces Merger with Clariti Health for Enhanced Patient Price Transparency Resources as Part of its End-to-End Premium Technology Solution
06/01/2021
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST...
06/01/2021
Vascular Disease Management
News
Cardiovascular Institute of the South (CIS) Completes First Procedure in New Ambulatory Surgery Center
01/05/2021
Cardiovascular Institute of the South (CIS) completed the first outpatient procedure today in its new Ambulatory Surgery Center (ASC) located at 191 Innovation Ct, Ste B in Gray, La. The peripheral angiogram was performed by world-renowned...
Cardiovascular Institute of the South (CIS) completed the first outpatient procedure today in its new Ambulatory Surgery Center (ASC) located at 191 Innovation Ct, Ste B in Gray, La. The peripheral angiogram was performed by world-renowned...
Cardiovascular Institute of the...
01/05/2021
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement